Perspective Therapeutics, Inc. — Investor Relations & Filings
Perspective Therapeutics, Inc. is a clinical-stage radiopharmaceutical company that pioneers advanced treatments for cancer. The company specializes in developing image-guided, targeted alpha-particle therapies (TATs). Its core technology utilizes the alpha-emitting isotope Lead-212 (Pb-212) conjugated to high-affinity, tumor-specific peptides to deliver potent radiation directly to cancer cells. This approach is designed to maximize efficacy against tumors while minimizing damage to surrounding healthy tissue. The company's theranostics platform uses the chemically matched isotope pair Pb-203/212, allowing physicians to visualize tumor targets to assist with patient selection and optimize treatment. Its clinical pipeline is focused on various cancers, including melanoma, neuroendocrine tumors, and other solid tumors.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 8-K | 2026-05-21 | English | |
| Major Shareholding Notification 2026 | 2026-05-12 | English | |
| 10-Q | 2026-05-11 | English | |
| 8-K | 2026-05-11 | English | |
| 8-K - Perspective Therapeutics, Inc. (0000728387) (Filer) | 2026-05-04 | English | |
| Major Shareholding Notification 2026 | 2026-04-27 | English |
Browse filings by year
22 years- 2026 24 filings
- 2025 63 filings
- 2024 101 filings
- 2023 70 filings
- 2022 42 filings
- 2021 40 filings
- 2020 53 filings
- 2019 44 filings
- 2018 61 filings
- 2017 56 filings
- 2016 45 filings
- 2015 40 filings
- 2014 41 filings
- 2013 28 filings
- 2012 41 filings
- 2011 39 filings
- 2010 33 filings
- 2009 27 filings
- 2008 29 filings
- 2007 52 filings
- 2006 81 filings
- 2005 15 filings
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 46798416 | 8-K | 2026-05-21 | English | ||
| 46082429 | Major Shareholding Notification 2026 | 2026-05-12 | English | ||
| 46082422 | 10-Q | 2026-05-11 | English | ||
| 46082499 | 8-K | 2026-05-11 | English | ||
| 41058612 | 8-K - Perspective Therapeutics, Inc. (0000728387) (Filer) | 2026-05-04 | English | ||
| 46082505 | Major Shareholding Notification 2026 | 2026-04-27 | English | ||
| 34690304 | 8-K - Perspective Therapeutics, Inc. (0000728387) (Filer) | 2026-04-20 | English | ||
| 46082502 | DEFA14A | 2026-04-16 | English | ||
| 46082608 | DEF 14A | 2026-04-16 | English | ||
| 33149933 | 8-K - Perspective Therapeutics, Inc. (0000728387) (Filer) | 2026-04-01 | English | ||
| 46082603 | 10-K | 2026-03-16 | English | ||
| 46082656 | 8-K | 2026-03-16 | English | ||
| 46082657 | Major Shareholding Notification 2026 | 2026-03-11 | English | ||
| 23425256 | SCHEDULE 13G Filing | 2026-02-12 | English | ||
| 18398441 | SCHEDULE 13G - Perspective Therapeutics, Inc. (0000728387) (Subject) | 2026-02-09 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Ajanta Pharma Ltd.
Specialty pharmaceutical firm focused on complex generics a…
|
AJANTPHARM | IN | Manufacturing |
|
Akari Therapeutics Plc
Develops next-gen antibody-drug conjugates using proprietar…
|
AKTX | US | Manufacturing |
|
Akebia Therapeutics, Inc.
A biopharmaceutical company that develops and commercialize…
|
AKBA | US | Manufacturing |
|
Akeso, Inc.
Global commercial-stage biopharma developing innovative ant…
|
9926 | KY | Manufacturing |
|
Aktis Oncology, Inc.
A clinical-stage biotech developing targeted alpha radiopha…
|
AKTS | US | Manufacturing |
|
Akums Drugs and Pharmaceuticals Limited
CDMO providing end-to-end pharmaceutical manufacturing and …
|
AKUMS | IN | Manufacturing |
|
Albert David Ltd.
Produces pharmaceutical formulations, infusions, and specia…
|
ALBERTDAVD | IN | Manufacturing |
|
Aldeyra Therapeutics, Inc.
Develops medications for immune-mediated ocular and systemi…
|
ALDX | US | Manufacturing |
|
Aleafia Health Inc.
Vertically integrated cannabis company with cultivation, pr…
|
AH | CA | Manufacturing |
|
Alector, Inc.
Clinical-stage biotech using immuno-neurology to treat neur…
|
ALEC | US | Manufacturing |
Perspective Therapeutics, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/33510/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=33510 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=33510 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=33510 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 33510}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Perspective Therapeutics, Inc. (id: 33510)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.